Announcements Trials

Browse Landscape

Status

Active not recruiting 1

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Head & Neck 1 Genitourinary 1 Breast 1

Conditions

HR+HER2- Advanced Breast Cancer 1

Interventions

Paclitaxel 161 Fulvestrant 155 Trastuzumab 152 pembrolizumab 144 Letrozole 136 Carboplatin 118 pertuzumab 104 Cyclophosphamide 102 Capecitabine 102 Specimen Handling 101 Anastrozole 90 palbociclib 85 abemaciclib 81 Magnetic Resonance Spectroscopy 81 exemestane 76 Docetaxel 76 Tamoxifen 75 ribociclib 73 trastuzumab deruxtecan 69 Radiotherapy 61 Biopsy 59 Surveys and Questionnaires 56 Gemcitabine 52 130-nm albumin-bound paclitaxel 52 sacituzumab govitecan 50 olaparib 50 Standard of Care 49 Blood Specimen Collection 49 Taxes 47 Doxorubicin 47

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Drug Therapy, Combination × Breast × 1 year × Clear all

NCT06148506 2025-12-05

ValerEE

Novartis

Active not recruiting

HR+HER2- Advanced Breast Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡